Evidence map›Paper›PMID 25284014›Full record

ArticleStem cells (Dayton, Ohio)2015

The orphan nuclear receptor NR4A1 specifies a distinct subpopulation of quiescent myeloid-biased long-term HSCs.

Ruben H Land, Anna K Rayne, Ashley N Vanderbeck, Trevor S Barlowe, Shwetha Manjunath, Matthew Gross, Sophie Eiger, Peter S Klein, Nicole R Cunningham, Jian Huang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. CDK6 Inhibition: A Novel Approach in AML Management.International journal of molecular sciences · 2020
    Review
  12. Article
  13. CDK6 coordinatesBlood · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ruben H LandDepartment of Microbiology and Immunology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York, USA.
Anna K Rayne
Ashley N Vanderbeck
Trevor S Barlowe
Shwetha Manjunath
Matthew Gross
Sophie Eiger
Peter S Klein
Nicole R Cunningham
Jian Huang
Stephen G Emerson
Jennifer A Punt
Columbia University Irving Medical Center · USHaverford College · USTemple University · USUniversity of Pennsylvania · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
Stem Cell Selection &Expansion Via HOX Gene ActivationR01CA090833 · NCI · UNIVERSITY OF PENNSYLVANIA · PI EMERSON, STEPHEN G · 2001 to 2010
$2.6M
Regulating Hematopoietic Stem Cell Homeostasis through GSK-3R01HL110806 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KLEIN, PETER S, TONG, WEI · 2011 to 2014
$2.1M
Targeting Wnt and mTOR to expand hematopoietic stem cellsR21HL107968 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI KLEIN, PETER S · 2011 to 2012
$440k
Howard Hughes Medical InstituteNCI NIH HHS 2R01CA090833NCI NIH HHS 5P30CA013696NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA090833NHLBI NIH HHS 1R01HL110806NHLBI NIH HHS R01 HL110806NHLBI NIH HHS R21 HL107968
6 · The paper itself

Abstract

Hematopoiesis is maintained throughout life by self-renewing hematopoietic stem cells (HSCs) that differentiate to produce both myeloid and lymphoid cells. The NR4A family of orphan nuclear receptors, which regulates cell fate in many tissues, appears to play a key role in HSC proliferation and differentiation. Using a NR4A1(GFP) BAC transgenic reporter mouse we have investigated NR4A1 expression and its regulation in early hematopoiesis. We show that NR4A1 is most highly expressed in a subset of Lin(-) Sca-1(+) c-Kit(+) CD48(-) CD150(+) long-term (LT) HSCs, and its expression is tightly associated with HSC quiescence. We also show that NR4A1 expression in HSCs is induced by PGE2, a known enhancer of stem cell engraftment potential. Finally, we find that both NR4A1(GFP+) and NR4A1(GFP-) HSCs successfully engraft primary and secondary irradiated hosts; however, NR4A1(GFP+) HSCs are distinctly myeloid-biased. These results show that NR4A1 expression identifies a highly quiescent and distinct population of myeloid-biased LT-HSCs.

Indexed as

AnimalsCell DifferentiationCell ProliferationHematopoietic Stem CellsMiceMice, Inbred C57BLNuclear Receptor Subfamily 4, Group A, Member 1Nr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1HematopoiesisHematopoietic stem cellMyeloid biasNR4A1 (Nur77)PGE2Quiescence

Identifiers

PMID25284014
PMCPMC4270858
OpenAlexW1956972180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.